Former Sen. Richard Burr has registered to lobby for the first time now that his two-year ban on lobbying former colleagues ...
Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...
Citi reiterated a Buy rating and $1,190 price target on Eli Lilly (LLY), saying the firm expects a positive read-through to the shares on FDA’s ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...
Sen. Richard Burr is mounting a comeback to Capitol Hill – as a registered lobbyist for Duke University and other clients ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...
The yearly pilgrimage in honor of St. Patrick’s Day came at a tense time for Ireland, with Irish Prime Minister Micheál ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results